BPC-157

The summary below reflects published preclinical and laboratory research and is provided for scientific reference only.

BPC-157 is a synthetic pentadecapeptide — a stable 15-amino-acid sequence derived from a protein found in gastric juice, from which it takes the name “Body Protection Compound.” It is one of the most extensively studied peptides in preclinical tissue-repair research, valued in the laboratory for its stability in aqueous solution.

Mechanism under investigation

Research in animal and cell models attributes BPC-157’s effects primarily to angiogenesis — the formation of new blood vessels. Studies describe upregulation of the VEGFR2 pathway and interaction with the nitric-oxide system, alongside modulation of growth-factor signaling that governs how connective tissue repairs itself. These are proposed mechanisms drawn from experimental models, not established clinical actions.

Research applications

The published literature centers on musculoskeletal and gastrointestinal models in rodents:

• Tendon-, ligament-, and muscle-injury healing in animal studies.
• Protection of gastrointestinal mucosa in experimental models.
• Vascular and growth-factor signaling relevant to soft-tissue repair.

State of the evidence

The overwhelming majority of BPC-157 data is preclinical — cell culture and animal models. Robust human clinical trials remain limited, and BPC-157 is not an approved therapeutic. Its promise in the literature is real but early, and should be read as a basis for further research rather than evidence of human benefit.